精华制药(002349) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥334,493,742.71, representing a 9.83% increase compared to ¥304,542,238.53 in the same period last year[9] - Net profit attributable to shareholders was ¥56,677,913.02, up 5.07% from ¥53,945,183.55 year-on-year[9] - Basic earnings per share rose to ¥0.0696, a 4.98% increase from ¥0.0663 in the same period last year[9] - The company reported a decrease of 1.37% in net profit after deducting non-recurring gains and losses, totaling ¥56,467,371.36 compared to ¥57,253,335.34 last year[9] - Net profit for the current period was ¥62,561,935.39, up 15.5% from ¥54,338,530.47 in the previous period[61] - The total comprehensive income attributable to the parent company was ¥56,677,913.02, compared to ¥53,945,183.55, an increase of 5.4%[64] Cash Flow - The net cash flow from operating activities increased by 39.81% to ¥67,386,448.72, compared to ¥48,197,106.08 in the previous year[9] - Cash received from other operating activities increased significantly to 33,060,451.62 from 13,321,216.32, a rise of 148.18% due to an increase in other cash receipts[22] - The company's cash flow from investment recovery increased to 36,124,715.80 from 23,211,200.00, a rise of 55.63% due to the maturity of financial products held by subsidiaries[22] - The company's cash and cash equivalents increased to 606,292,455.51 from 581,318,648.60, reflecting a positive cash flow position[39] - The cash and cash equivalents at the end of the period increased to 600,739,319.32 from 295,650,387.20, indicating a significant rise of approximately 102.3%[78] - The company’s cash flow from financing activities resulted in a net outflow of -49,608,535.09, compared to -69,261,726.12 in the previous period, showing an improvement of approximately 28.4%[78] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,160,957,880.85, a slight increase of 0.16% from ¥3,156,027,189.46 at the end of the previous year[9] - The company's total liabilities decreased to ¥610,717,479.17 from ¥669,288,963.02, a reduction of approximately 8.73%[45] - Current liabilities totaled ¥530,738,103.66, a marginal increase from ¥528,484,288.86, representing a growth of about 0.24%[45] - The company's long-term borrowings decreased from 60,000,000.00 to 120,000,000.00, a reduction of 50.00% as a subsidiary reclassified long-term borrowings to current liabilities[22] - The total current assets amounted to ¥451,213,691.56, slightly down from ¥458,006,194.54, a decrease of about 1.73%[49] Shareholder Information - The top shareholder, Nantong Industrial Holding Group Co., Ltd., holds 34.29% of the shares, with a total of 286,592,160 shares[14] - Net assets attributable to shareholders increased by 2.72% to ¥2,164,817,838.44 from ¥2,107,504,709.65 at the end of the previous year[9] - The total equity attributable to shareholders increased to ¥2,164,817,838.44 from ¥2,107,504,709.65, reflecting a growth of about 2.72%[48] Expenses and Investments - Total operating costs increased to ¥275,205,754.61 from ¥238,064,393.99, reflecting a rise of 15.6%[58] - Research and development expenses increased by 14,562,216.19 to 9,899,701.65, a rise of 47.10% due to increased investment in technological innovation[22] - The company reported a decrease in financial expenses from 595,347.23 to 3,789,040.81, a decline of 84.29% due to reduced interest payments on bank loans[22] - Investment income decreased to 1,168,845.34 from 2,670,961.73, a drop of 56.24% primarily due to reduced profits from an associated company[22] - The company reported an investment income of ¥940,187.81, down from ¥2,670,961.73, a decrease of 64.8%[65] Other Information - The company did not engage in any repurchase transactions during the reporting period[19] - The first quarter report for 2021 was not audited[86] - The company did not require adjustments to the beginning balance of the balance sheet due to the adoption of the new leasing standards, as it only has short-term leasing operations[85]